Showing results (111-120 of 378) with videos related to
Sort By:
Pageof 38
Statistics in Medicine|December 14, 2011
Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trialsLindsay A Renfro, Qian Shi, Daniel J Sargent, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 24, 2010
Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory studyAraba A Adjei, Oreste E Salavaggione, Sumithra J Mandrekar, et al.Annals of Surgical Oncology|July 8, 2021
Impact of the COVID-19 Pandemic on Cancer Clinical TrialsJudy C Boughey, Rebecca A Snyder, Olga Kantor, et al.Molecular Genetics and Genomics : MGG|August 23, 2006
Analysis of S-RNase alleles of almond (Prunus dulcis): characterization of new sequences, resolution of synonyms and evidence of intragenic recombinationEncarnación Ortega, Radovan I Bosković, Daniel J Sargent, et al.JAMA Oncology|April 19, 2017
Use of Bayesian Decision Analysis to Minimize Harm in Patient-Centered Randomized Clinical Trials in OncologyVahid Montazerhodjat, Shomesh E Chaudhuri, Daniel J Sargent, et al.Nature Reviews. Clinical Oncology|September 4, 2013
Drug rechallenge and treatment beyond progression--implications for drug resistanceElizabeth A Kuczynski, Daniel J Sargent, Axel Grothey, et al.Cancer|October 21, 2010
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trialsNathan R Foster, Yingwei Qi, Qian Shi, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Comparative bioavailability of sulindac in capsule and tablet formulationsJoel M Reid, Sumithra J Mandrekar, Elsa C Carlson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non-small cell lung cancerAlex A Adjei, Julian R Molina, Sumithra J Mandrekar, et al.Nature Reviews. Clinical Oncology|April 7, 2010
Biomarkers and surrogate end points--the challenge of statistical validationMarc Buyse, Daniel J Sargent, Axel Grothey, et al.Pageof 38